Posted in | News | Industrial Robotics

Rockwell Develops ControlLogix to Handle Kuka’s PA Robots

Rockwell, in partnership with Kuka, has developed a new controller termed as ControlLogix Programmable Automation Controllers (PACs), which can effectively control PA robots of Kuka. This product will be showcased at the Pack Expo event, which will be held in Chicago.

This innovation offers an open design featuring single programming environment termed as RSLogix 5000 as well as one PAC for handling an entire robot. The company has reported that the new controller will offer high productivity throughout the life cycle of the robot and the controlling parts are well optimized for providing simplified automation layout. It also features an established user-machine interface.

James Cooper, Kuka’s VP for Sales and Marketing in the US, expressed happiness over providing the world’s first integrated controller. He added that this innovation was accomplished by means of a combined robotic technology that enabled ControlLogix of Rockwell to control Kuka’s PA robot.

Source: http://www.rockwellautomation.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Rockwell Automation, Inc.. (2019, February 21). Rockwell Develops ControlLogix to Handle Kuka’s PA Robots. AZoRobotics. Retrieved on April 24, 2024 from https://www.azorobotics.com/News.aspx?newsID=311.

  • MLA

    Rockwell Automation, Inc.. "Rockwell Develops ControlLogix to Handle Kuka’s PA Robots". AZoRobotics. 24 April 2024. <https://www.azorobotics.com/News.aspx?newsID=311>.

  • Chicago

    Rockwell Automation, Inc.. "Rockwell Develops ControlLogix to Handle Kuka’s PA Robots". AZoRobotics. https://www.azorobotics.com/News.aspx?newsID=311. (accessed April 24, 2024).

  • Harvard

    Rockwell Automation, Inc.. 2019. Rockwell Develops ControlLogix to Handle Kuka’s PA Robots. AZoRobotics, viewed 24 April 2024, https://www.azorobotics.com/News.aspx?newsID=311.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.